* A study recruited 26 nonsmoking CM patients to assess carboxyhemefibrinogen and iron-bound fibrinogen formation, along with their coagulation status using specific testing methods.
* Results showed a high occurrence of fibrinogen modifications (88.5%) and notable hypercoagulability among CM patients, suggesting a need for further research into CO and iron's roles as potential treatment targets for CM-related pain and vascular diseases.